Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer’s disease

Title
Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer’s disease
Authors
Keywords
Oligomers, Alzheimers disease, Biomarkers, Cerebrospinal fluid, Immunotherapy, Jugular vein, Enzyme-linked immunoassays, Antibodies
Journal
PLoS One
Volume 12, Issue 4, Pages e0174630
Publisher
Public Library of Science (PLoS)
Online
2017-04-11
DOI
10.1371/journal.pone.0174630

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More